Keyphrases
Type 2 Diabetes Prevention
100%
Pioglitazone
100%
Thiazolidinediones
75%
Type 2 Diabetes Mellitus (T2DM)
50%
Cardiovascular Risk
25%
Obesity
25%
Beneficial Effects
25%
Lipid Metabolism
25%
Insulin Resistance
25%
Glycemic Control
25%
Population Aging
25%
New Drugs
25%
Peroxisome Proliferator-activated Receptor
25%
Pleotropic Effects
25%
PPARγ Agonist
25%
Cardiovascular Safety
25%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
100%
Pioglitazone
100%
Thiazolidinedione
75%
Insulin Resistance
25%
Cardiovascular Risk
25%
Peroxisome Proliferator Activated Receptor
25%
Peroxisome Proliferator Activated Receptor Gamma Agonist
25%